Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Maria Berkman

AddedMar 31, 2024

UpdatedMay 31, 2026

Maria Berkman

Maria Berkman

Board Member, Lyra Therapeutics

Crunchbase LinkedIn

Maria Berkman's Career

Lyra Therapeutics

Lyra Therapeutics

Watertown, MA, US

Board Member· Board

Zumbro Discovery

Zumbro Discovery

Rochester, NY, US

Board Member· Board

BioKier

Chapel Hill, NC, US

Board Member· Board

AtaCor Medical

San Clemente, CA, US

Board Member· Board

Aria CV

Saint Paul, MN, US

Board Member· Board

Adient Medical

Pearland, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Maria Berkman's Career

Lyra Therapeutics

Lyra Therapeutics

Public$264.1M662014Watertown, MA, US

Board Member· Board

Leadership at Lyra Therapeutics

George WhitesidesCo-Founder

Nancy SnydermanBoard Member

Paulina HillBoard Member

Bob LangerBoard Member

Guido NeelsBoard Member

Konstantin PoukalovBoard Member

Similar to Lyra Therapeutics

LyndraWatertown, MA, USPharmaceuticals, Therapiesest. 2015LyndraWatertown, MA, US · est. 2015

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Series E · $284.6M161

Lyric PharmaceuticalsSan Francisco, CA, USTherapeuticsest. 2013Lyric PharmaceuticalsSan Francisco, CA, US · est. 2013

Lyric, a clinical-stage company, innovates gastrointestinal therapeutics for unmet hospital needs.

Series A · $20.4M6

Cara TherapeuticsStamford, CT, USDrugs, Therapeuticsest. 2004Cara TherapeuticsStamford, CT, US · est. 2004

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Public · $517.2M106

Cyrano TherapeuticsDelray Beach, FL, USPharmaceuticals, Therapeuticsest. 2014Cyrano TherapeuticsDelray Beach, FL, US · est. 2014

Cyrano Therapeutics: Innovating intranasal solutions to restore taste and smell functions.

Series B · $21.8M7

Zumbro Discovery

Zumbro Discovery

Series A$1M62013Rochester, NY, US

Board Member· Board

Leadership at Zumbro Discovery

Horng ChenCo-Founder

John BurnettCo-Founder

BioKier

Angel$2.9M52008Chapel Hill, NC, US

Board Member· Board

Leadership at BioKier

Roger NolanCo-Founder

Jerzy SzewczykCo-Founder

Similar to BioKier

EIR PharmaceuticalsDover, DE, USHealth Products, Pharmaceuticalsest. 2018EIR PharmaceuticalsDover, DE, US · est. 2018

EIR Pharmaceuticals: A biotech startup specializing in developing and commercializing health and wellness products.

Kira PharmaceuticalsCambridge, MA, USBiotechnology, Therapeuticsest. 2017Kira PharmaceuticalsCambridge, MA, US · est. 2017

Kira Pharmaceuticals: A global biotech leader, pioneering in complement disease therapies, with a robust pipeline.

Series B · $99.5M27

BioQ PharmaSan Francisco, CA, USDrugs, Pharmaceuticalsest. 2003BioQ PharmaSan Francisco, CA, US · est. 2003

BioQ Pharma, a San Francisco-based specialty pharma company, develops ready-to-use infusible drugs to minimize medication errors globally.

Series B · $107.8M25

JK BioPharma SolutionsPotomac, MD, USBiotechnologyest. 2013JK BioPharma SolutionsPotomac, MD, US · est. 2013

JK BioPharma Solutions, Inc.: A Maryland-based biotechnology firm in the healthcare industry since 2013.

AtaCor Medical

Series B$34M232014San Clemente, CA, US

Board Member· Board

Leadership at AtaCor Medical

Gary GershonyBoard Member

Jeff TerrellBoard Member

Rick SangheraFounder

Similar to AtaCor Medical

Atrility MedicalMadison, WI, USMedical Devicesest. 2017Atrility MedicalMadison, WI, US · est. 2017

Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.

Series A · $4M9

CormedicsHouston, TX, USMedical Devicesest. 1989CormedicsHouston, TX, US · est. 1989

Cormedics Corp. is a medical device company innovating in cardiac treatments, focusing on rhythm management, atrial fibrillation, and targeted therapies.

CoraVie MedicalMinneapolis, MN, USMedical Devicesest. 2020CoraVie MedicalMinneapolis, MN, US · est. 2020

MedTech firm pioneering a subcutaneous blood pressure monitor for uncontrolled hypertension.

Protaryx MedicalBaltimore, MD, USMedical Devicesest. 2019Protaryx MedicalBaltimore, MD, US · est. 2019

Protaryx Medical: Innovating left atrium access for transcatheter cardiac procedures.

Series A · $8.3M8

Aria CV

Acquired$53.7M02010Saint Paul, MN, US

Board Member· Board

Leadership at Aria CV

Jason RushtonBoard Member

Darshana ZaveriBoard Member

John ScandurraCo-Founder

Karl VollmersCo-Founder

Dan GladneyBoard Member

Similar to Aria CV

AvicenaPasadena, CA, USMedical Devicesest. 2014AvicenaPasadena, CA, US · est. 2014

Avicena: Innovating cardiovascular health with advanced medical devices and algorithms.

Pre-Seed · $2.5M24

Aqua HeartSanta Ana, CA, USMedical Devicesest. 2017Aqua HeartSanta Ana, CA, US · est. 2017

AQUA Heart, Inc.: A leading MedTech firm in Santa Ana, CA, innovating in cardiovascular care and AF therapy.

CardiovateSan Antonio, TX, USMedical Devicesest. 2012CardiovateSan Antonio, TX, US · est. 2012

Cardiovate: A med-tech company focusing on tissue regeneration and repair in healthcare.

CvrxMinneapolis, MN, USMedical Devicesest. 2001CvrxMinneapolis, MN, US · est. 2001

CVRx, Inc.: Global provider of innovative, implantable medical devices for hypertension and heart failure treatment.

Public · $390.6M160

Adient Medical

Series B$17.5M112012Pearland, TX, US

Board Member· Board

Leadership at Adient Medical

Mitch EggersFounder

Robert TucciBoard Member

Similar to Adient Medical

EmboMedicsMaple Grove, MN, USMedical Devicesest. 2012EmboMedicsMaple Grove, MN, US · est. 2012

EmboMedics: Developing and commercializing resorbable, drug-loaded embolization devices since 2012.

Pre-Seed · $7.6M5

Advanced Medical Device TechnologiesNewport Beach, CA, USMedical Devicesest. 2019Advanced Medical Device TechnologiesNewport Beach, CA, US · est. 2019

Advanced Medical Device Technologies: Your trusted provider of innovative medical device designs.

Early Bird MedicalMalvern, PA, USMedical Devicesest. 2020Early Bird MedicalMalvern, PA, US · est. 2020

Early Bird Medical: Revolutionizing women's health through innovative medical devices.

Series A · $17.2M8

Adapta MedicalColorado Springs, CO, USMedical Devicesest. 2005Adapta MedicalColorado Springs, CO, US · est. 2005

Adapta Medical: Innovating urinary catheterization systems for various health conditions since 2005.

Angel · $225k6

Maria Berkman's Similar Executives & Operators

Jay Geoffrey WacherBoard Member · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

WILL WEI CHENGBoard Member · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

Mason YeoBoard Member · Kakao

JaeHong ChoiBoard Member · Kakao

Yun SeokBoard Member · Kakao

People Similar to Maria Berkman

Michael PirronBoard Member · Social Venture Circle

Mark D. StolperBoard Member · Coherus BioSciences

Maria SeilerBoard Member · Broadview Ventures

Bernard GoldsteinFounder · Broadview Associates

Gavin ChristensenFounder · Kickstart

Hilary GosherBoard Member · Alma